This study is testing new medicines for adults with Ulcerative Colitis (UC) and Crohn's Disease (CD), which are types of inflammatory bowel diseases. These are conditions that cause swelling and sores in the digestive tract. Participants must have had UC or CD for at least 3 months and show certain signs of active disease. The study will last about 62 weeks. People who have tried medicines like corticosteroids (drugs to reduce swelling) or immunomodulators (drugs to help the immune system) and didn’t get better can join. Some people cannot join, like those who have had serious surgeries, have other bowel complications, or have failed too many other treatments. The study will help find out if new treatments are safe and effective.
- Length: The study will take at least 62 weeks.
- Eligibility: Only adults with a confirmed diagnosis of UC or CD can participate.
- Exclusions: Certain surgeries or other conditions might prevent participation.
How understandable was the trial content above?
Hard to understand
Easy to understand